Literature DB >> 10570945

A disulfide conjugate between anti-tetanus antibodies and HIV (37-72)Tat neutralizes tetanus toxin inside chromaffin cells.

S Stein1, A Weiss, K Adermann, P Lazarovici, J Hochman, H Wellhöner.   

Abstract

Conjugates between anti-tetanus F(ab')2 fragments and the (37-72) fragment of the HIV Tat protein were taken up by chromaffin cells, NG108-15 neurohybridoma cells and Rev-2-T-6 lymphoma cells. The uptake could not be inhibited by competition with (37-72)Tat, but was reduced in the presence of metabolic inhibitors or at low temperature. The disulfide as well as the thioether conjugate were translocated to the cytoplasmic space, but only the disulfide conjugate moderately restored the stimulated transmitter release inhibited by tetanus toxin. Therefore, disulfide conjugates are more promising than thioethers for the neutralization of intracellular antigens. These conjugates provide new tools to study neuroprotection against bacterial neurotoxins.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10570945     DOI: 10.1016/s0014-5793(99)01186-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  7 in total

Review 1.  Targeting antibodies to the cytoplasm.

Authors:  Andrea L J Marschall; André Frenzel; Thomas Schirrmann; Manuela Schüngel; Stefan Dübel
Journal:  MAbs       Date:  2011-01-01       Impact factor: 5.857

2.  Cell-penetrating peptides and antibodies: a new direction for optimizing radioimmunotherapy.

Authors:  Maneesh Jain; Ganesh Venkatraman; Surinder K Batra
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-07       Impact factor: 9.236

3.  Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting.

Authors:  Simon Beaudoin; Michel Paquette; Laurent Fafard-Couture; Mylene A Tremblay; Roger Lecomte; Brigitte Guérin; Jeffrey V Leyton
Journal:  J Vis Exp       Date:  2018-03-08       Impact factor: 1.355

4.  Novel human-derived cell-penetrating peptides for specific subcellular delivery of therapeutic biomolecules.

Authors:  Catherine De Coupade; Antonio Fittipaldi; Vanessa Chagnas; Matthieu Michel; Sophie Carlier; Ennio Tasciotti; Audrey Darmon; Denis Ravel; Jonathan Kearsey; Mauro Giacca; Françoise Cailler
Journal:  Biochem J       Date:  2005-09-01       Impact factor: 3.857

5.  HIV TAT Protein Transduction Domain Mediated Cell Binding and Intracellular Delivery of Nanoparticles.

Authors:  J Andrew Mackay; Francis C Szoka
Journal:  J Dispers Sci Technol       Date:  2003       Impact factor: 2.262

6.  TAT peptide and its conjugates: proteolytic stability.

Authors:  Jacob Grunwald; Tomas Rejtar; Rupa Sawant; Zhouxi Wang; Vladimir P Torchilin
Journal:  Bioconjug Chem       Date:  2009-07-14       Impact factor: 4.774

7.  Interaction of the protein transduction domain of HIV-1 TAT with heparan sulfate: binding mechanism and thermodynamic parameters.

Authors:  André Ziegler; Joachim Seelig
Journal:  Biophys J       Date:  2004-01       Impact factor: 4.033

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.